UK Companies House feature
WEB PHARMACY LIMITED
Cash
£1M
+42.7% vs 2024
Net assets
£1M
+0.5% vs 2024
Employees
83
-3.5% vs 2024
Profit before tax
£277K
+897% vs 2024
Profile
- Company number
- SC361420
- Status
- Active
- Incorporation
- 2009-06-18
- Last accounts made up
- 2025-02-28
- Account category
- FULL
- Primary SIC
- 47730
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-02-28
| Metric | Trend | 2019-02-28 | 2020-02-28 | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | -£34,708 | £276,607 | |
| Net profit | — | — | — | — | — | -£218,908 | £6,035 | |
| Cash | — | — | — | — | — | £810,311 | £1,156,564 | |
| Total assets less current liabilities | — | — | — | — | — | £6,648,520 | £7,555,901 | |
| Net assets | — | — | — | — | — | £1,162,020 | £1,168,055 | |
| Equity | £519,834 | £443,312 | — | — | — | £1,162,020 | £1,168,055 | |
| Average employees | — | — | — | — | — | 86 | 83 | |
| Wages | — | — | — | — | — | £2,690,638 | £2,753,738 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Thomson Cooper
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors expect that the company has adequate resources to continue in operational existence for a period of not less than twelve months. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EMBREY, Michael | Secretary | 2024-02-16 | — | — |
| CRUICKSHANK, Alexander Douglas Miller | Director | 2010-08-01 | Feb 1975 | British |
| WICKS, Noel James | Director | 2009-06-18 | May 1977 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MCDONALD, Stefan David | Director | 2009-12-23 | 2012-09-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Myob Holdings Limited | Corporate entity | Shares 25–50% | 2023-10-31 | Active |
| Cross Healthcare Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-06-19 | Ceased 2023-10-31 |
| Right Medicine Pharmacy Limited | Corporate entity | Shares 50–75%, Voting 50–75% | 2016-06-19 | Active |
Filing timeline
Last 20 of 121 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-03-02 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2026-03-02 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2026-01-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-11-19 | AA | accounts | accounts with accounts type full |
| 2025-02-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-26 | AA | accounts | accounts with accounts type full |
| 2024-03-27 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-22 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-03-21 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
Credit score
Altman Z″ (private-firm) · reference 2025-02-28
1.69
GREY ZONE
Altman Z″
- Working capital / Total assets 0.138 × 6.56 = +0.91
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.090 × 6.72 = +0.60
- Book equity / Total liabilities 0.175 × 1.05 = +0.18
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory